Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?
James G. MarkenSVP OPS PROD DEV2024-06-075,300$57.06
James G. MarkenSVP OPS PROD DEV2024-06-0711,087$67.70
James G. MarkenSVP OPS PROD DEV2024-06-077,250$49.51
Ori GutwergSVP GENERICS2024-06-052,985$67.00
Stephen P. CareySVP CFO2024-06-045,000$63.58
Chad GassertSVP - CORP. DEV. STRATEGY2024-06-0320,000$64.41
Christopher MutzHEAD OF RARE DISEASE2024-05-212,000$61.61
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2024-05-2012,855$61.81
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2024-05-175,836$62.09
Muthusamy ShanmugamHEAD OF RD COO-NOVITIUM OPS2024-05-1616,459$63.84

1 of 13

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?
Meridian Venture Partners Ii LP89.34%18,737,728$1.20BInsider
Robert E. Brown Jr.80.90%16,967,490$1.09BInsider
Ross J. Mangano27.62%5,792,084$371.91MInsider
Blackrock Inc12.07%2,531,343$162.54MInstitution
Tracy Marshbanks11.01%2,308,568$148.23MInsider
Vanguard Group Inc6.23%1,306,432$83.89MInstitution
Rubric Capital Management LP4.57%958,533$61.55MInstitution
Victor A. Morgenstern4.46%936,014$60.10MInsider
Deep Track Capital LP3.92%822,001$52.78MInstitution
Muthusamy Shanmugam3.87%811,272$52.09MInsider

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP22.61%77.39%Net SellingNet Selling
PCRX68.67%31.33%Net SellingNet Selling
TLRY11.05%2.17%Net BuyingNet Buying
SUPN45.07%54.93%Net SellingNet Buying
AVDL72.86%13.53%Net Selling

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 67.26% institutional shareholders, 230.19% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners Ii LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 89.34% of the company. Meridian Venture Partners Ii LP's Ani Pharmaceuticals shares are currently valued at $1.18B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.